Cephalexin oral suspension recalled for incorrect dose labeling
Bryant Ranch Prepack is recalling 61 bottles of Cephalexin for Oral Suspension due to a back label stating an incorrect dose amount—5g instead of 10g per bottle.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class III recall with a labeling error—a documentation issue. No illnesses or injuries are reported. The actual product is correct; only the back label contains inaccurate dosage information.
Plain-English summary
Bryant Ranch Prepack, Inc. is recalling 61 bottles of Cephalexin for Oral Suspension, USP, 250mg/5mL nationwide due to a labeling error on the back label.
The back label incorrectly states 'Each contains: cephalexin monohydrate, USP equivalent to 5g' when it should state 'Each Bottle contains: cephalexin monohydrate, USP equivalent to 10g.' This discrepancy could cause patients to misunderstand the actual dose content of the product.
The recalled product includes lot numbers 235067 (expires 12/31/2025), 235289 (expires 11/30/2025), and 235290 (expires 12/31/2025). Consumers should stop using the product and contact their pharmacist or healthcare provider for guidance.
The recalled product
- Product
- CEPHALEXIN (CEPHALEXIN)
- Brand
- CEPHALEXIN
- Manufacturer
- Bryant Ranch Prepack, Inc.
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot: 235067
- Exp 12/31/2025
- 235289
- Exp 11/30/2025
- 235290
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CEPHALEXIN
- LowCephalexin for Oral Suspension Recalled for Back Label Error
FDA (Drugs) · 2024-06-12
- ModerateCephalexin oral suspension recalled for incorrect label dosage amount
FDA (Drugs) · 2024-06-12
- LowCephalexin Oral Suspension Recalled for Incorrect Labeling and Missing Dosage Information
FDA (Drugs) · 2024-06-12
- ModerateCephalexin Oral Suspension Recalled for Incorrect Dosage Label
FDA (Drugs) · 2024-06-12
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27